[go: up one dir, main page]

DK3171857T3 - Kombination af adapalen og benzoylperoxid til behandling af alvorlig acne - Google Patents

Kombination af adapalen og benzoylperoxid til behandling af alvorlig acne Download PDF

Info

Publication number
DK3171857T3
DK3171857T3 DK15736304.5T DK15736304T DK3171857T3 DK 3171857 T3 DK3171857 T3 DK 3171857T3 DK 15736304 T DK15736304 T DK 15736304T DK 3171857 T3 DK3171857 T3 DK 3171857T3
Authority
DK
Denmark
Prior art keywords
adapalene
combination
benzoyl peroxide
treat severe
severe acne
Prior art date
Application number
DK15736304.5T
Other languages
English (en)
Inventor
Matthew James Leoni
Michael Graeber
Vasant Manna
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53540775&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3171857(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Application granted granted Critical
Publication of DK3171857T3 publication Critical patent/DK3171857T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/327Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK15736304.5T 2014-07-25 2015-07-16 Kombination af adapalen og benzoylperoxid til behandling af alvorlig acne DK3171857T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462029043P 2014-07-25 2014-07-25
PCT/EP2015/066331 WO2016012352A1 (en) 2014-07-25 2015-07-16 Combination of adapalene and benzoyl peroxide for the treatment of severe acne

Publications (1)

Publication Number Publication Date
DK3171857T3 true DK3171857T3 (da) 2020-09-21

Family

ID=53540775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15736304.5T DK3171857T3 (da) 2014-07-25 2015-07-16 Kombination af adapalen og benzoylperoxid til behandling af alvorlig acne

Country Status (24)

Country Link
US (2) US20170216231A1 (da)
EP (1) EP3171857B1 (da)
KR (1) KR20170035916A (da)
CN (1) CN107072939A (da)
AU (1) AU2015294100A1 (da)
BR (1) BR112017001434A2 (da)
CL (1) CL2017000088A1 (da)
CY (1) CY1124107T1 (da)
DK (1) DK3171857T3 (da)
ES (1) ES2828699T3 (da)
HR (1) HRP20201787T1 (da)
HU (1) HUE051351T2 (da)
IL (1) IL250199A0 (da)
LT (1) LT3171857T (da)
MA (1) MA40179B1 (da)
MX (1) MX2017000717A (da)
PT (1) PT3171857T (da)
RS (1) RS61017B1 (da)
RU (1) RU2017105074A (da)
SG (1) SG11201700449RA (da)
SI (1) SI3171857T1 (da)
SM (1) SMT202000705T1 (da)
TW (1) TW201609082A (da)
WO (1) WO2016012352A1 (da)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833841B1 (fr) 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
SI1485080T1 (sl) * 2002-03-12 2009-10-31 Galderma Res & Dev Uporaba adapalena za zdravljenje dermatoloških motenj
FR2903603B1 (fr) 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
FR2909000B1 (fr) * 2006-11-28 2009-02-06 Galderma Res & Dev S N C Snc Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations.
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
EP2282731A1 (en) * 2008-04-24 2011-02-16 Galderma Research & Development Combination therapy for acne vulgaris comprising adapalene 0.3% gel with clindamycin/benzoyl peroxide gel
WO2012129499A1 (en) * 2011-03-23 2012-09-27 The Regents Of The University Of California Treatment of inflammatory and infectious skin disorders
US20160310512A1 (en) * 2013-12-19 2016-10-27 Galderma Research & Development Therapy regimen for treating severe acne related diseases

Also Published As

Publication number Publication date
RU2017105074A3 (da) 2019-01-15
HRP20201787T1 (hr) 2021-04-16
MA40179B1 (fr) 2020-10-28
ES2828699T3 (es) 2021-05-27
US20170095434A1 (en) 2017-04-06
EP3171857A1 (en) 2017-05-31
WO2016012352A1 (en) 2016-01-28
MX2017000717A (es) 2017-05-01
RS61017B1 (sr) 2020-12-31
HUE051351T2 (hu) 2021-03-01
CN107072939A (zh) 2017-08-18
EP3171857B1 (en) 2020-08-19
PT3171857T (pt) 2020-11-19
IL250199A0 (en) 2017-03-30
BR112017001434A2 (pt) 2017-12-05
RU2017105074A (ru) 2018-08-27
KR20170035916A (ko) 2017-03-31
SI3171857T1 (sl) 2021-01-29
CL2017000088A1 (es) 2017-09-01
TW201609082A (zh) 2016-03-16
US20170216231A1 (en) 2017-08-03
AU2015294100A1 (en) 2017-01-12
MA40179A (fr) 2017-05-31
CY1124107T1 (el) 2022-03-24
SG11201700449RA (en) 2017-02-27
SMT202000705T1 (it) 2021-01-05
LT3171857T (lt) 2021-01-11

Similar Documents

Publication Publication Date Title
IL253463A0 (en) Binding-triggered transcriptional switches and methods of use thereof
GB2521881B (en) Auto-tuning of non-linear processor threshold
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
IL263680A (en) Combination therapies
DK3134530T3 (da) Behandling af hyperbilirubinæmi
HUE066839T2 (hu) Eljárások kardiovaszkuláris kockázat csökkentésére
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
DK3204497T3 (da) Terapeutisk hæmning af lactatdehydrogenase og midler dertil
LT3149345T (lt) Būdas dviem objektams sujungti
DK3132009T3 (da) Fremgangsmåde
PL3189074T3 (pl) Kompozycje oraz sposoby leczenia i zapobiegania zapaleniom
DK3034552T4 (da) Synergistic visbreaking-sammensætning af peroxid og hydroxylaminester til øgning af visbreaking-effektivitet
DK3283210T3 (da) Fremgangsmåde
DK3159296T3 (da) Reb til elevator og fremstillingsfremgangsmåde dertil
DK3326635T3 (da) Behandling og forebyggelse af forkølelse ved hjælp af povidon-iod
DK3240821T3 (da) Lavdosis gashydrathæmmersammensætning og tilhørende fremgangsmåde
KR20180084892A (ko) 소비 장치의 안전한 제어
FI20155709L (fi) Rinnakkain kytkettyjen teholaitteiden ohjaus
DK3180335T3 (da) Cytokrom-p450-inhibitorer og anvendelser deraf
DK3229811T3 (da) Forebyggelse og behandling af betændelseslidelser
DK3233104T3 (da) Immunterapi-behandlinger og -sammensætninger
DK3215221T3 (da) Fremgangsmåder og sammensætninger til sikker og effektiv trombolyse
DK3200783T3 (da) Behandling af erytromelalgi
SG11201608222WA (en) Combination of adapalene and benzoyl peroxide for treating acne scars